TruBridge, Inc. (NASDAQ: TBRG) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 90.48 | EPS (ttm) | 0.29 | Insider Own | - | Shs Outstand | 15.00M | Perf Week | -0.04% |
| Market Cap | 393.58M | Forward P/E | 8.87 | EPS next Y | 2.96 | Insider Trans | 0.00% | Shs Float | 14.35M | Perf Month | 0.65% |
| Enterprise Value | 524.58M | PEG | 7.63 | EPS next Q | - | Inst Own | - | Short Float | 3.82% | Perf Quarter | 45.94% |
| Income | 6.00M | P/S | 1.14 | EPS this Y | 820.69% | Inst Trans | - | Short Ratio | 1.66 | Perf Half Y | 15.59% |
| Sales | 346.00M | P/B | 2.20 | EPS next Y | 10.74% | ROA | 1.08% | Short Interest | 548.56K | Perf YTD | 18.89% |
| Book/sh | 11.93 | P/C | 11.24 | EPS next 5Y | 11.86% | ROE | 2.48% | 52W High | 26.51 -1.02% | Perf Year | 14.29% |
| Cash/sh | 2.33 | P/FCF | 9.38 | EPS past 3/5Y | -35.49% -21.61% | ROIC | -54.87% | 52W Low | 13.88 89.05% | Perf 3Y | 7.41% |
| Dividend Est. | - | EV/EBITDA | 15.90 | Sales past 3/5Y | 2.00% 5.62% | Gross Margin | 51.23% | Volatility | 0.05% 0.13% | Perf 5Y | -20.02% |
| Dividend TTM | - | EV/Sales | 1.52 | EPS Y/Y TTM | 121.01% | Oper. Margin | 5.96% | ATR (14) | 0.06 | Perf 10Y | -34.27% |
| Dividend Ex-Date | Aug 14, 2020 | Quick Ratio | 1.77 | Sales Y/Y TTM | 0.87% | Profit Margin | 1.27% | RSI (14) | 79.10 | Recom | 2.68 |
| Dividend Gr. 3/5Y | -29.33% -34.87% | Current Ratio | 1.78 | EPS Q/Q | 63.89% | SMA20 | 0.21% | Beta | 1.27 | Target Price | 26.25 |
| Payout | 0.00% | Debt/Eq | 0.93 | Sales Q/Q | -1.15% | SMA50 | 0.85% | Rel Volume | 0.00 | Prev Close | 26.24 |
| Employees | 3,500 | LT Debt/Eq | 0.91 | Earnings | Aug 06 | SMA200 | 21.02% | Avg Volume | 337.51K | Price | 26.24 |
| IPO Date | May 21, 2002 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -6.23% -8.64% | Net Debt/EBITDA | 4.09 | Volume | 0 | Change | 0.00% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Apr-27-26 | Reiterated | Deutsche Bank | Hold | $23 → $26 |
| Apr-24-26 | Reiterated | BMO Capital | $15 → $26 | |
| Apr-24-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral | $26 |
| Apr-24-26 | Downgrade | Freedom Capital Markets | Buy → Hold | |
| Jan-09-26 | Resumed | RBC Capital | Sector Perform | $13 → $23 |
| May-13-24 | Reiterated | Deutsche Bank | Hold | $11 |
| Mar-28-24 | Reiterated | RBC Capital | $13 | |
| Sep-10-20 | Upgrade | Keybanc | Underweight → Sector Weight | |
| May-08-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight | |
| Sep-10-19 | Upgrade | Dougherty & Co. | Neutral → Buy |
TruBridge, Inc. delivers a comprehensive suite of healthcare solutions and services to community hospitals, clinics, and various medical facilities, both within the United States and globally. Its operations are structured around three core divisions: Revenue Cycle Management (RCM), Electronic Health Record (EHR), and Patient Engagement. The company places a strong emphasis on its RCM offerings, which are designed to integrate seamlessly with any primary healthcare information solutions provider. These offerings are complemented by business management, consulting, managed IT services, and sophisticated analytics and business intelligence tools. Its extensive RCM services span the entire revenue cycle, including patient liability estimates, eligibility verification, precise claim scrubbing and submission, remittance and denial/audit management, and contract management. Further capabilities include accounts receivable management, private pay services, medical coding, specialized revenue cycle consulting, and a range of additional insurance and patient billing services. TruBridge also provides specialized acute care solutions and associated services for community hospitals and physician clinics. Moreover, it leverages patient engagement and empowerment technologies to enhance patient outcomes and improve interaction strategies with care providers. Beyond these, the company offers general consulting and business management expertise, managed IT services, encoder solutions, patient management, financial accounting, and a suite of clinical, patient care, and enterprise applications. Its flagship TruBridge HER platform is a robust offering, encompassing total system support, access to national client conferences, continuing education resources, regular software releases, hardware replacement, and cloud-based electronic health record functionality, all built upon a secure public cloud infrastructure. Additionally, TruBridge supplies post-acute care software systems with comprehensive support and maintenance, alongside innovative tools like InstantPHR (an interactive patient portal) and CHBase, which efficiently centralizes data from diverse sources. Founded in 1979, the company recently underwent a rebranding from Computer Programs and Systems, Inc. to TruBridge, Inc. in March 2024. Its corporate headquarters are located in Mobile, Alabama.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 346 | 347 | 343 | 339 | 327 | 281 | 264 | 275 | 280 | |
| Cost of Goods Sold Incl. D&A | 168 | 163 | 169 | 176 | 167 | 136 | 128 | 130 | 141 | |
| Gross Profit | 177 | 184 | 174 | 164 | 160 | 145 | 136 | 144 | 139 | |
| Selling, General and Administrative Excl. Other | 110 | 104 | 104 | 104 | 82 | 70 | 70 | 72 | 78 | |
| Research and Development | 39 | 33 | 34 | 37 | 31 | 30 | 33 | 37 | 36 | |
| Other Operating Expense | 8 | 26 | 29 | 65 | 24 | 20 | 12 | 11 | 0 | |
| Operating Income | 21 | 21 | 7 | -43 | 23 | 25 | 21 | 25 | 25 | |
| Interest Expense | 5 | 12 | 16 | 13 | 6 | 3 | 4 | 7 | 8 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -15 | -5 | -1 | 1 | 2 | 2 | 1 | 6 | 1 | |
| Net Income Before Taxes | 0 | 4 | -10 | -54 | 18 | 23 | 19 | 24 | 18 | |
| Income Taxes | -5 | 0 | 10 | -9 | 2 | 5 | 5 | 3 | 0 | |
| Consolidated Net Income | 6 | 4 | -20 | -46 | 16 | 18 | 14 | 20 | 17 | |
| Net Income From Continuing Operations | 6 | 4 | -20 | -46 | 16 | 18 | 14 | 20 | 18 | |
| Net Income | 6 | 4 | -20 | -46 | 16 | 18 | 14 | 20 | 17 | |
| EPS (Recurring) | 0.29 | 0.29 | -1.38 | -3.15 | 1.08 | 1.26 | 0.98 | 1.43 | 1.26 | |
| EPS (Basic, Before Extraordinaries) | 0.29 | 0.29 | -1.38 | -3.15 | 1.08 | 1.26 | 0.98 | 1.43 | 1.26 | |
| EPS (Diluted) | 0.29 | 0.29 | -1.38 | -3.15 | 1.08 | 1.26 | 0.98 | 1.43 | 1.26 | |
| EBITDA | 33 | 42 | 35 | -15 | 48 | 43 | 36 | 43 | 38 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 90.48 | 76.10 | — | — | 25.20 | 23.25 | 27.39 | 18.46 | 19.92 | |
| Price To Sales Ratio | 1.14 | 0.89 | 0.80 | 0.46 | 1.17 | 1.46 | 1.42 | 1.34 | 1.26 | |
| Gross Margin | 51.16 | 53.03 | 50.73 | 48.38 | 48.93 | 51.60 | 51.52 | 52.36 | 49.64 | |
| Operating Margin | 6.07 | 6.05 | 2.04 | -12.68 | 7.03 | 8.90 | 7.95 | 9.09 | 8.93 | |
| Net Margin | 1.73 | 1.15 | -5.83 | -13.57 | 4.89 | 6.41 | 5.30 | 7.27 | 6.07 | |
| Shares Outstanding | 15 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |
| Market Capitalization | 394 | 309 | 276 | 157 | 381 | 410 | 376 | 370 | 351 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Pinetree Capital Ltd. | 10% Owner | Dec 03 '25 | Buy | 23.00 | 10,000 | 230,000 | 2,130,000 | Dec 03 |
| Pinetree Capital Ltd. | 10% Owner | Dec 02 '25 | Buy | 22.72 | 45,000 | 1,022,400 | 2,120,000 | Dec 03 |
| Pinetree Capital Ltd. | 10% Owner | Dec 01 '25 | Buy | 22.40 | 75,000 | 1,680,000 | 2,075,000 | Dec 03 |
| Pinetree Capital Ltd. | 10% Owner | Nov 19 '25 | Buy | 20.63 | 13,501 | 278,571 | 2,000,000 | Nov 20 |
| Pinetree Capital Ltd. | 10% Owner | Nov 18 '25 | Buy | 20.84 | 3,639 | 75,837 | 841,499 | Nov 19 |
| Pinetree Capital Ltd. | 10% Owner | Nov 17 '25 | Buy | 20.42 | 20,707 | 422,837 | 837,860 | Nov 19 |
| Daughton Michael | Chief Business Officer | Nov 17 '25 | Buy | 20.46 | 17,500 | 358,050 | 57,492 | Nov 18 |
| Daughton Michael | Chief Business Officer | Nov 14 '25 | Buy | 20.15 | 2,500 | 50,375 | 39,992 | Nov 18 |
| Daughton Michael | Chief Business Officer | Nov 13 '25 | Buy | 20.16 | 4,354 | 87,777 | 37,492 | Nov 18 |
| Daughton Michael | Chief Business Officer | Nov 12 '25 | Buy | 19.95 | 10,167 | 202,832 | 33,138 | Nov 18 |
| Daughton Michael | Chief Business Officer | Nov 11 '25 | Buy | 19.39 | 15,479 | 300,138 | 22,971 | Nov 18 |
| Pinetree Capital Ltd. | 10% Owner | Nov 14 '25 | Buy | 20.23 | 18,933 | 383,015 | 817,153 | Nov 14 |
| Pinetree Capital Ltd. | 10% Owner | Nov 13 '25 | Buy | 20.41 | 21,035 | 429,324 | 798,220 | Nov 14 |
| Pinetree Capital Ltd. | 10% Owner | Nov 12 '25 | Buy | 19.94 | 8,935 | 178,164 | 777,185 | Nov 14 |
| Harse David | General Manager Patient Care | Mar 14 '25 | Sale | 27.40 | 1,744 | 47,786 | 18,058 | Aug 15 |